Predictive factors of psoriatic arthritis in a diverse population with psoriasis

被引:3
作者
Loo, Wai Yang [1 ]
Tee, Ying Chew [1 ]
Han, Winn Hui [2 ]
Faheem, Nik Aimee Azizah [2 ]
Yong, Shin Shen [2 ]
Kwan, Zhenli [2 ]
Pok, Lydia Say Lee [1 ]
Yahya, Fariz [1 ,3 ]
机构
[1] Univ Malaya, Dept Med, Div Rheumatol, Kuala Lumpur, Malaysia
[2] Univ Malaya, Dept Med, Div Dermatol, Kuala Lumpur, Malaysia
[3] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia
关键词
Predictive factor; psoriatic arthritis; psoriasis; prediction; retrospective cohort study; risk factor; DISEASE SEVERITY; RISK-FACTORS; DERMATOLOGY; PREVALENCE; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT; DIAGNOSIS; PATTERNS; CARE;
D O I
10.1177/03000605231221014
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
ObjectiveWe aimed to analyze the clinical characteristics of patients with psoriasis and determine the predictive factors of psoriatic arthritis (PsA).MethodsThis retrospective cohort study was performed among patients with psoriasis. Demographic and clinical data were collected. Psoriasis treatment was categorized as topical agents, phototherapy, oral therapy, and biologics. Predictive factors of PsA development were determined using logistic regression analyses.ResultsWe included 330 patients with psoriasis, and 83 (25%) patients developed PsA. Thirty-eight (45.8%) patients who developed PsA were Malay, 24 (28.9%) were Chinese, and 21 (25.3%) were Indian. The mean age of patients with PsA was 54.2 (+/- 15.8) years, and the duration from diagnosis of psoriasis to diagnosis of PsA was 36 (3.5-114) months. Predictive factors for developing PsA were female sex (odds ratio [OR] = 3.33, 95% confidence interval [CI] 1.78-6.22), presence of nail involvement (OR = 5.36, 95% CI 2.50-11.51), severe psoriasis (OR = 27.41, 95% CI 7.58-99.11), and oral systemic therapy prior to PsA diagnosis (OR = 4.09, 95% CI 2.04-8.22).ConclusionPatients with psoriasis who are female, have nail involvement, severe skin psoriasis, and require oral systemic therapy for psoriasis may have an increased risk of developing PsA.
引用
收藏
页数:12
相关论文
共 43 条
  • [11] Psoriasis assessment tools in clinical trials
    Feldman, SR
    Krueger, GG
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 65 - 68
  • [12] Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis
    Gisondi, Paolo
    Bellinato, Francesco
    Targher, Giovanni
    Idolazzi, Luca
    Girolomoni, Giampiero
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (01) : 68 - 73
  • [13] Psoriatic arthritis: epidemiology, clinical features, course, and outcome
    Gladman, DD
    Antoni, C
    Mease, P
    Clegg, DO
    Nash, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 14 - 17
  • [14] Inflammatory marker alteration in response to systemic therapies in psoriasis
    Grechin, Cristina
    Gheuca Solovastru, Laura
    Vata, Dan
    Ionela Patrascu, Adriana
    Ioana Grajdeanu, Alina
    Porumb-Andrese, Elena
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (01) : 42 - 46
  • [15] Griffiths CEM, 2021, LANCET, V397, P1301, DOI 10.1016/S0140-6736(20)32549-6
  • [16] Haroon M., 2018, Annals of the Rheumatic Diseases, V77, P378
  • [17] Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis
    Haroon, Muhammad
    Gallagher, Phil
    FitzGerald, Oliver
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1045 - 1050
  • [18] Psoriasis and psoriatic arthritis in African-American patients-the need to measure disease burden
    Kerr, Gail S.
    Qaiyumi, Seema
    Richards, John
    Vahabzadeh-Monshie, Hashem
    Kindred, Chesahna
    Whelton, Sean
    Constantinescu, Florina
    [J]. CLINICAL RHEUMATOLOGY, 2015, 34 (10) : 1753 - 1759
  • [19] Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis
    Langenbruch, A.
    Radtke, M. A.
    Krensel, M.
    Jacobi, A.
    Reich, K.
    Augustin, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (05) : 1123 - 1128
  • [20] Malaysia Ministry of Health, 2013, Manegement of Psoriasis Vulgaris, P66